Skip to main content

What’s on the Horizon for Chronic Lymphocytic Leukemia?

May 8, 2018

Topics Covered

We invite you to learn more about:

  • Diagnosing chronic lymphocytic leukemia (CLL)
  • New and emerging therapies
  • Supportive care and side-effects management
  • The importance of shared decision making when discussing treatment



Matthew S. Davids, MD, MMSc
Associate Director
Center for Chronic Lymphocytic Leukemia
Assistant Professor of Medicine
Harvard Medical School
Dana Farber Institute
Boston, MA

Audio Replay

Program Materials

Program Support

Support for this program provided by AbbVie; Genentech and Biogen; Pharmacyclics, an AbbVie Company and Janssen Biotech.



< Back to Webcasts